An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

• Status: Completed
• Trial end date: 1969-12-31

Summary

To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.

• Phase: N/A

Details

• Lead Sponsor: Janssen, LP
• Treatments: Fluconazole; Hydroxyitraconazole; Itraconazole